Evidence map›Paper›PMID 38686875›Full record

ArticleJournal of the American Heart Association2024

Heart Failure-Related Death in Subjects With Atrial Fibrillation in the United States, 1999 to 2020.

Marco Zuin, Matteo Bertini, Francesco Vitali, Mintu Turakhia, Giuseppe Boriani

Abstract read
In one paragraph

Article in Journal of the American Heart Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Rare TruncatingGenes · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Discovery ofDiagnostics (Basel, Switzerland) · 2025
    Article
  9. Article
  10. Article
  11. Trends in atrial fibrillation-related mortality among adults under 65 years in the USA.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Genomic medicine for heart failure prediction in patients with atrial fibrillation.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Article
  16. Identification and Functional Investigation ofDiagnostics (Basel, Switzerland) · 2024
    Article
  17. Global burden of atrial fibrillation/atrial flutter and its attributable risk factors from 1990 to 2021.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Marco ZuinCardiology Unit, Department of Translational Medicine Sant'Anna University Hospital, University of Ferrara Ferrara Italy.ORCID 0000-0002-4559-1292
Matteo BertiniCardiology Unit, Department of Translational Medicine Sant'Anna University Hospital, University of Ferrara Ferrara Italy.ORCID 0000-0002-5285-7140
Francesco VitaliCardiology Unit, Department of Translational Medicine Sant'Anna University Hospital, University of Ferrara Ferrara Italy.ORCID 0000-0002-0667-7616
Mintu TurakhiaDivision of Cardiovascular Medicine, The Center for Digital Health Stanford University Stanford CA USA.ORCID 0000-0001-8025-0904
Giuseppe BorianiCardiology Division, Department of Biomedical, Metabolic and Neural Sciences Italy University of Modena and Reggio Emilia, Policlinico di Modena Modena Italy.ORCID 0000-0002-9820-4815

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPopulation-based data on heart failure (HF)-related death in patients with atrial fibrillation (AF) are lacking. We assessed HF-related death in people with AF in the United States over the past 21 years and examined differences by age, sex, race, ethnicity, urbanization, and census region. METHODS AND

resultsData were extracted from the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research to determine trends in age-adjusted mortality rates per 100 000 people, due to HF-related death among subjects with AF aged ≥15 years. To calculate nationwide annual trends, we assessed the average annual percent change (AAPC) and annual percent change with relative 95% CIs using joinpoint regression. Between 1999 and 2020, 916 685 HF-related deaths (396 205 men and 520 480 women) occurred among US adults having a concomitant AF. The overall age-adjusted mortality rates increased (AAPC: +4.1% [95% CI, 3.8-4.4];

conclusionsA worrying increase in the HF-related mortality rate among patients with AF has been observed in the United States over the past 2 decades.

Indexed as

Atrial FibrillationHeart FailureAdolescentAdultAgedAged, 80 and overAge DistributionCause of DeathCOVID-19FemaleHumansMaleMiddle AgedRisk FactorsSARS-CoV-2United Statesatrial fibrillationdeathheart failuretrends

Identifiers

PMID38686875
PMCPMC11179935

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.